Suppr超能文献

磷酸化-去磷酸化对剪接因子ASF/SF2的活性有不同影响。

Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.

作者信息

Xiao S H, Manley J L

机构信息

Department of Biological Sciences, Columbia University, New York, NY 10027, USA.

出版信息

EMBO J. 1998 Nov 2;17(21):6359-67. doi: 10.1093/emboj/17.21.6359.

Abstract

SR proteins are a conserved family of splicing factors that function in both constitutive and activated splicing. We reported previously that phosphorylation of the SR protein ASF/SF2 enhances its interaction with the U1 snRNP-specific 70K protein and is required for the protein to function in splicing, while other studies have provided evidence that subsequent dephosphorylation can also be required for SR protein function, at least in constitutive splicing. We now show that the phosphorylation status of ASF/SF2 can differentially affect several properties of the protein. In keeping with a dynamic cycle of phosphorylation-dephosphorylation during splicing, ASF/SF2 phosphorylation was found to affect interaction with several putative protein targets in different ways: positively, negatively or not at all. Extending these results, we also show that, in contrast to constitutive splicing, dephosphorylation is not required for ASF/SF2 to function as a splicing activator. We discuss these results with respect to the differential protein-protein interactions that must occur during constitutive and activated splicing.

摘要

SR蛋白是一类保守的剪接因子家族,在组成型剪接和激活型剪接中均发挥作用。我们之前报道过,SR蛋白ASF/SF2的磷酸化增强了其与U1 snRNP特异性70K蛋白的相互作用,并且是该蛋白在剪接中发挥功能所必需的,而其他研究则提供了证据表明,至少在组成型剪接中,SR蛋白功能随后的去磷酸化也可能是必需的。我们现在表明,ASF/SF2的磷酸化状态可以不同地影响该蛋白的几种特性。与剪接过程中磷酸化-去磷酸化的动态循环一致,发现ASF/SF2磷酸化以不同方式影响与几种假定的蛋白质靶点的相互作用:正向、负向或完全无影响。扩展这些结果,我们还表明,与组成型剪接不同,ASF/SF2作为剪接激活剂发挥功能不需要去磷酸化。我们就组成型剪接和激活型剪接过程中必然发生的不同蛋白质-蛋白质相互作用来讨论这些结果。

相似文献

引用本文的文献

3
Dysregulation and therapeutic targeting of RNA splicing in cancer.癌症中 RNA 剪接的失调和治疗靶标。
Nat Cancer. 2022 May;3(5):536-546. doi: 10.1038/s43018-022-00384-z. Epub 2022 May 27.
4
Aberrant RNA splicing and therapeutic opportunities in cancers.癌症中异常的 RNA 剪接和治疗机会。
Cancer Sci. 2022 Feb;113(2):373-381. doi: 10.1111/cas.15213. Epub 2021 Nov 30.
9
Altered RNA Processing in Cancer Pathogenesis and Therapy.癌症发病机制和治疗中的 RNA 加工改变。
Cancer Discov. 2019 Nov;9(11):1493-1510. doi: 10.1158/2159-8290.CD-19-0399. Epub 2019 Oct 14.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验